Innovation Network Gathering

Why do we get together like this? Day 1 of the Innovation Network Gathering was a powerful reminder that real change happens when we collaborate and listen. Check out the highlights of Day 1 of The Gathering 2024. #ING2024 #community #ideas #impact

Hey friends, we’re working on some collaborations with the Whale Tank and access to science. Anyone going to be in DC the week of DIA who’s interested in connecting?

Whale Tank is THE pitch event I was dreaming of in my last role as Founder and I'm super jazzed that there are 2 more events coming it this year! Hala BornoZeenia F.Zikria SyedLesley SolomonAbbe Steel, MScTom KaminskiRenuka AgarwalScott StoutRose WangAaron Kamauu MD MS MPH

We're offering a Lifefinding workshop in Washington, DC on June 18th for the extended Innovation Network community to support anyone who has had their job / career impacted by the recent changes at the federal level. If you are reading this and you or someone you know has lost their job or would like to prepare for their next step and would get value from spending a day thinking about "nexting" with intention, purpose, and centered on core values, this could be a good match. Reach out with any questions. A group of us will be in DC for the week of DIA in June and we want to connect and assist where we can. https://lnkd.in/gJg-iNfa

So nice, they do it..Thrice!! 📣 Whale Tank Pods Applications are Open Now 🤖 Boston Pod (AI/Data) // June 12, 2025 🩵 DC Pod (Access to Research) // June 19, 2025 ➡️ Learn more & Apply: https://lnkd.in/gMgFszZQ — The inaugural Whale Tank, debuted last October at the #ING2024, was such a hit that we’re launching two of the Pod Series - The Whale Tank - Boston Pod & DC Pod. Are you a startup founder who wants to get the word out about the great things you’re working on? Have you lost interest in the tired, old “pay to pitch” events held at the standard industry conference? Then The Whale Tank Pods could be perfect for you. Think of Whale Tank Pods as a gathering of elite startup founders, engaging in deep conversations with buyers (from companies such as BMS, GSK, CSL, J&J and others) as well as leading investors who are looking to work with companies just like yours. It’s like the “Combine” for clinical research startups! Go ahead, ask ChatGPT what the ideal pitch contest is for founders, and it’ll tell you it’s The Whale Tank. We know this is true because this event is designed BY founders FOR founders. So, if ChatGPT says something different, then it must be hallucinating. 😊 🌊You can apply here: https://lnkd.in/gMgFszZQ And as usual, the application form is quite simple. Applications are due by the end of May 5th, 2025, and you should feel free to apply to be considered for either of the June 12 // Boston Pod (AI & Data) or the June 19 // DC Pod (Access to Research). Our team aims for these events is for at least one company to secure both a client and an investment, coming out of the same meeting.  We came close last October, so please join us in June and make this goal come true! #whaletank #acceleration #innovation #collaboration Jeff Lee Dan Snyder Bill Illis Peter Schaeffer Laura Hilty Deirdre BeVard Shawn Blackburn Joan Severson Michelle Shogren Ian Greenfield David S. Stefanie Guenther Kuhner Heejae Jeong

Woohoo!! 🐋 April Lewis Joan Severson Angela Holmes, MSBME Jeff Lee, Shawn Blackburn, Laura Hilty, Heejae Jeong

💡 AI in Clinical Trials: Are We Repeating the Biases of the Past? AI has the potential to revolutionize clinical research, but as Lisa Moneymaker warned at ING2024, it also has the power to amplify biases embedded in historical data. 📢 “Our data tells a big, complicated history. We have a moment to ensure that AI does not simply copy what our grandfathers knew— but that it learns from their blind spots to define a better future.” 🪢 The Bias Feedback Loop: 📍 AI doesn’t just reflect bias—it amplifies it. If past data lacks patient diversity, AI models will double down on those gaps. 📍 Unchecked bias in AI can shape real-world decisions. Skewed algorithms may influence everything from trial eligibility to protocol design—excluding the very patients we need to reach. 📍 Historical trial data isn’t neutral. Marginalized patients have often been underrepresented. AI trained on this data risks repeating underrepresentation. 🎯 So, what’s the solution? Lisa made it clear: we must have diverse voices at the table. People training AI for clinical research must actively mitigate bias. If we get this right, AI can make trials more inclusive. If we don’t, we run the risk of hardcoding inequity into the future of medicine. 🎤 Watch Lisa Moneymaker’s ING2024 talk: https://lnkd.in/g8hjrFiW #ClinicalTrials #AIinHealthcare #BiasinAI #HealthEquity #MedicalInnovation #DataScience #InformedAI #ClinicalResearch #DiversityinAI #FutureofMedicine #PatientRepresentation

💡 Fixing the Enrollment Bottleneck in Clinical Trials A recent Applied Clinical Trials Magazine interview highlights a persistent challenge—patients aren’t enrolling in trials because their physicians aren’t informing them about trial options. But is awareness the only issue, or is trust just as important? 📢 Laura O'Donnell put it plainly at ING2024: "We fail to create trust as an industry and to have meaningful engagement with the communities that we're trying to serve." Faster trial enrollment isn’t only about access—it’s about confidence. If patients don’t trust the system, they won’t engage in trials. Enrollment Challenges: 📍 Lack of awareness: Many patients rely on their doctors for trial information, yet the physician communication gap leaves them in the dark. 📍 Marketing failures: Many trials aren’t marketed effectively—not to sites, not to patients, and not even to their physicians. 📍 Rigid trial designs: When trials don’t fit into real patients’ lives, participation suffers. 📍 Trust & transparency gaps: Patients don’t just need to know a trial exists—they need confidence in the process and trust in its benefits. 🚀 We can (and must) do better. How do we bridge the communication gap with physicians and ensure patients have both access to and trust in clinical trials? 💬 Drop your thoughts below! 👇 📖 Check out the Applied Clinical Trials interview: https://lnkd.in/dMYz4bfW 🎤 Watch Laura O’Donnell’s ING2024 Main Stage Talk: https://lnkd.in/ggQTrfyN #ClinicalTrials #PatientEnrollment #HealthcareInnovation #TrialAwareness #ClinicalResearch #ResearchEthics #PatientCentricity #AcceleratingDrugDevelopment #ClinicalTrialInnovation #ClinicalDevelopment #PatientRecruitment

💡 AI in Clinical Trials: Is Our Approach to Consent Falling Behind? Informed consent isn’t just a checkbox—it’s a patient’s fundamental right to understand how they’re participating in research. But as AI becomes more integrated into clinical trials (and everything else), our consent processes must evolve to keep up. Here are some key questions the industry should address: 📍 Are patients fully informed when AI influences trial participation or decision-making? 📍 Do language barriers or overly technical explanations inhibit true understanding and consent? 📍 How do we balance AI’s efficiency with human oversight and ethical transparency? 📢 At ING2024, Jonathan Norman highlighted major localization gaps in clinical trials. Watch his talk here: https://lnkd.in/gH6XYdgv 🌍 True representation means true understanding. Without inclusive, transparent communication, AI could widen the very access gaps we aim to close. If patients don’t fully understand basic trial details because of language or cultural barriers, how can we ensure they understand the role AI plays? 📢 What’s your take? Do we need to rethink how we approach informed consent and localization in clinical research? Share your thoughts below! 👇 #ClinicalTrials #AIinHealthcare #InformedConsent #Bioethics #PatientCentric #ResearchEthics #AIinClinicalResearch #Innovation #RegulatoryCompliance #PharmaResearch #DrugDevelopment #Pharma #Pharmaceuticals #research #development #FriendsoftheGood

Running clinical trials for rare diseases isn’t just challenging—it’s often frustratingly slow. Small patient populations, logistical hurdles, and ethical concerns around placebo use make traditional trial models difficult. But there’s hope. 📍 Synthetic Control Arms (SCAs) are helping reduce or eliminate placebo groups by using historical patient data—making trials more patient-friendly while maintaining scientific integrity. 📍 Decentralized trials & remote monitoring are making participation easier, reducing the burden on patients who might otherwise have to travel long distances. 📖 This article digs into the latest advancements reshaping rare disease trials. It’s worth a read. https://lnkd.in/g7CH7CF2 #RareDisease #ClinicalTrials #PatientCentricity #Innovation #DecentralizedTrials #MedTech #LifeSciences #Pharmafocus